Pete Hudson - Profile and Investment Details

Investor Profile

Pete Hudson is a Venture Capital, Private Equity Firm, Investor based in Denver, Colorado, United States with a diverse investment portfolio that includes companies such as United Musculoskeletal Partners, Lassen Therapeutics, Avid Radiopharmaceuticals, Nereus Pharmaceuticals, Calistoga Pharmaceuticals, Chimerix, Harbor Health, Sutro Biopharma, Larimar Therapeutics, Emergency Medicine Physicians, Aegis Semiconductor, Esperion Therapeutics, Taligen Therapeutics, Coapt Systems, Tyra Biosciences, GenePeeks, DispatchHealthChemoCentryx, Sunesis Pharmaceuticals, Intradigm Corporation, SurgRx, PneumRx, PatientsLikeMe, Cara Therapeutics, Immune Design, Sonexa Therapeutics, Trevena, Excaliard Pharmaceuticals, Xelerated, MacroGenics, St. George's University, SARcode Bioscience, US Acute Care Solutions, Neothetics, Kite Pharma, Sierra Surgical, VertiFlex, Virobay, Free Market Health, CymaBay Therapeutics, Allakos, EGenesis, ZS Pharma, Everside Health, Portola Pharmaceuticals, TransMedics, Maestro Health, BetterVet, Aegerion Pharmaceuticals, Vir Biotechnology, Pathwork Diagnostics, MAKO Surgical, CuraSen Therapeutics, Aerovance, Achaogen, Evofem Biosciences, Aerie Pharmaceuticals, Be Biopharma, Anesiva, Kiadis Pharma, Tivity Health, Carbylan Therapeutics, PatientsLikeMe, LLC., Applied Genetics Technologies Corporation, Variant Bio, Lumena Pharmaceuticals, Corcept Therapeutics, Transcarent, aTyr Pharma, Foldrx Pharmaceuticals, 7TM Pharma, Novome Biotechnologies, Qihan Biotech, . Over time, Pete Hudson has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Pete Hudson is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Hospitals, Genetics, Wellness, Women Founded, Healthcare Innovation, Life Science, Medical Technologies, Information Services, Software, Biotechnology, Consumer Health, Medical Devices, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Clinical Trials, Home Care, Gene Therapy, Telehealth, Digital Health, Medical, Information Technology, B2B, Therapeutics, Health Tech, Cellular Therapy, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Pete Hudson, as their portfolio suggests a familiarity and interest in this area.

Understanding Pete Hudson’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.